Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-01-01 @ 1:51 PM
Study NCT ID:
NCT00796757
Status:
COMPLETED
Last Update Posted:
2015-05-27
First Post:
2008-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-12
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-21
First Submit QC Date:
None
Study First Post Date:
2008-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-08-04
Results First Submit QC Date:
None
Results First Post Date:
2015-05-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-05-22
Last Update Post Date:
2015-05-27
Last Update Post Date Type:
ESTIMATED